Peer Review History
| Original SubmissionSeptember 20, 2021 |
|---|
|
PONE-D-21-30400Describing and overcoming barriers to care home staff using non-pharmacological strategies for sleep disturbances in care home residents with dementia: the SIESTA qualitative studyPLOS ONE Dear Dr. Webster, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. All the three reviewers have highlighted positive aspects in the manuscript. Yet, they all have comments at the methodological and conceptual level that I kindly ask the authors to carefully address. On the basis of the revision I will be able to make an evaluation about publication. Please submit your revised manuscript by Feb 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sara Rubinelli Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please describe in your methods section how capacity to provide consent was determined for the participants in this study. Please also state whether your ethics committee or IRB approved this consent procedure. If you did not assess capacity to consent please briefly outline why this was not necessary in this case. 3. Thank you for stating the following financial disclosure: The SEISTA study was funded as part of an Economic and Social Research Council (ESRC) PhD studentship awarded to LW, and surpvised by SC and GL.
Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments/ Funding Section of your manuscript: The SEISTA study was funded as part of an Economic and Social Research Council (ESRC) funded PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: The SEISTA study was funded as part of an Economic and Social Research Council (ESRC) PhD studentship awarded to LW, and surpvised by SC and GL. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Competing Interests section: LW reports that the analyses in this paper were undertaken as part of their ESRC funded PhD studentship. SGC reports receiving research funding from Alzheimer's Research UK Grant, European Research Council and Dunhill Medical Trust. GL reports participating on the Lancet Healthy Longevity Board and receiving research funding from Alzheimer's Society, Wellcome trust, and NIHR. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. 7. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 8. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Staff used a range of techniques that often worked in reducing or preventing sleep disturbance. Some common techniques, such as caffeinated drinks, may be counterproductive. Non-pharmacological interventions should consider practical difficulties in limiting daytime napping, identifying residents night-time needs; day-night disorientation, and insufficient night staffing. This is an useful study. I find appropriate a short introduction in aging and sheep disturbances, useful. Reviewer #2: This is an interesting manuscript that reports a qualitative study on factors that affect sleep behaviour for people with dementia in residential care settings. An adequate number of interviews were undertaken across four facilities, and the results are presented in a well-structured form. Overall, an important contribution. I would consider the manuscript to be very well constructed and have no particular suggestions regarding the methodology and results. However, the paper does bring to light certain practises and attitudes that perhaps could be further pursued or at least discussed. In such a qualitative study, it would have been useful to understand the care ‘lens’ through which aged care workers and nurses undertook their roles. While it is laudable that staff would pursue non-pharmacological means to reduce sleep disturbances, from the descriptions of attitudes, it was not clear how person-centred these approaches may be. While intentions may have been good, many of the described practises could be perceived as manipulative and coercive, especially around activities and attempts to promote wakefulness during the day. I am wondering if the authors may have data on attitudes regarding the autonomy and ability for residents to make choices about their daily and nightly activities? From some descriptions, certain practices could be interpreted as physical restraint. It may not be available, but it would be interesting to know the extent to which staff have received education or training specifically on dementia? Perhaps some of these issues could be considered in the Discussion. Small correction: note spelling ‘SEISTA’ on line 432 (Funding Sources) Reviewer #3: Manuscript review: Describing and overcoming barriers to home staff using non-pharmacological strategies for sleep disturbances in care home residents with dementia: the SIESTA qualitative study. Submitted to PLOS ONE. December 2021 Thank you for the opportunity to review this paper. According to the title, the focus is on (1) “describing and overcoming barriers” to the use of non-pharmacological strategies for sleep disturbances for (2) people with dementia in residential care. I comment on these two issues as they do not seem to be the focus of the paper. Information on “barriers to managing sleep disturbances” (Results) is not presented until page 12 (line 259) and appears minimal compared to the presented information on strategies. Further, on page 19 (line 414+) the authors write that “we did not check the diagnoses of the residents” so there is an assumption about residents having dementia that may be incorrect. Financial disclosure – please correct the spelling/typographical error. Page 1 (line 3): Suggest deleting the second mention of “care home” Abstract (page 2) Background – please correct the grammar in the initial sentences: “care homes” should be singular; “It is “should be “They are” (relating to sleep disturbances” Methods: Clarify how many times you interviewed the staff. Results: Information from “During the daytime ….” to “They used telecare to monitor night-time risk” seems to fit better in Methods. Given the title of the paper, I would expect data-based information about barriers to be presented in the Results. Conclusions: The “range of techniques” mentioned here seems to fit better in Results. Line 40: “residents night-time needs” should be residents’ night-time needs Page 3 Line 47: delete “base” Line 48: Move “of hypnotics” to follow “randomised controlled trials; explain hypnotics Line 55: Delete “however” Line 59: Spell out NICE before you use the abbreviation Line 62: Include further details about the evidence supporting multi-component approaches to sleep disturbances. Later, in your Results section, you talk about the strategies staff used. I need to understand these strategies and that understanding needs to come from the detailed information you present in your Introduction. Line 64: End the sentence after “residents with dementia.” Next sentence could be “These factors include noise (17), light (18), other residents’ (correct the position of the apostrophe; and make this correction on page 4, line 68; and on page 15, line 318) wakefulness …. Page 4 Line 75: End the sentence after “residents with dementia.” Delete mention of the interviews. Including this information suggests you have already published the results of the interviews in reference 3. If this is true, the current paper does not need to be published. Make sure your research question for the current paper is clearly stated. Page 5 Line 93: Change “do” to “did” Line 100: Include information on the length of the interviews and when they were completed Line 104: Provide further details on “altered the guide iteratively” Page 6 Line 110: Who transcribed the interviews? Need further details here. If the first author transcribed all the interviews, there is the risk of bias. You mention further down that two authors developed the thematic coding framework but I am confused about the sequence of events. Please explain what occurred when there was uncertainly or disagreement about coding. Page 7 Line 122: Much of what is presented here seems to fit better in your earlier Methods section. Line 132: Please describe your participants as well as refer to Table 1. I would like to know more about whether/how your 8+6 care staff were educated about evidence-based strategies. Line 138: You need a transition here e.g., “Details are presented in the following sections” so that a reader knows details are forthcoming. Line 139: Your subheading is “Daytime strategies” so on line 140, suggest deleting “To prevent night-time sleep disturbances”. Page 9 Line 172: Change ‘do” to “go” Page 15 - Discussion. Line 308: Please address your research question - which, given your title, appears to be on addressing barriers – and explore the reasons for these. I feel that when you mention barriers, you are listing them and making general statements rather than delving into why they occurred and citing evidence to support how they might be overcome. I understand that your focus is on non-pharmacological strategies, but I think you need to address the drugs that residents have been prescribed. This is missing from the current paper and is relevant, particularly in relating to residents’ apparent fatigue and sleepiness during the day. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Aurel Popa-Wagner Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-30400R1How do care home staff use non-pharmacological strategies to manage sleep disturbances in residents with dementia: the SIESTA qualitative studyPLOS ONE Dear Dr. Webster, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers are overall satisfied with the revision that improved the overall quality of the study-presentation. One reviewer still has some minor suggestions that I kindly ask you to consider before I can make a final decision on publication. Please submit your revised manuscript by Aug 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sara Rubinelli Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have adequately addressed my concerns. Good study albeit not being very innovative. The manuscript can be published in its present form Reviewer #2: A thoughtful revision - my concerns have been largely addressed. The Paper will be of interest in the care sector. Reviewer #3: Thank you for your careful attention to my earlier comments and suggestions. I have a few more for clarity and grammar: - Please check your use of "residents" and make the needed correction when you mean the possessive form, i.e. residents' - On page 10, line 193: please change the heading to "Evening strategies to promote sleep" This then matches the earlier heading of "Daytime strategies..." I ask you to delete "good" as you have not measured the quality of sleep. -On page 11, line 210: please change the heading to "Night-time strategies to manage sleep". - Page 15, line 296: Change "these" to "sleep" -Page 20, line 409: Change "is" to "are" (but there are often...) - Page 21, line 431: Change "females" to "female" Thank you ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Aurel Popa-Wagner Reviewer #2: Yes: James Vickers Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
How do care home staff use non-pharmacological strategies to manage sleep disturbances in residents with dementia: the SIESTA qualitative study PONE-D-21-30400R2 Dear Dr. Webster, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sara Rubinelli Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-30400R2 How do care home staff use non-pharmacological strategies to manage sleep disturbances in residents with dementia: the SIESTA qualitative study Dear Dr. Webster: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sara Rubinelli Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .